Australia Metagenomics Market Size & Outlook, 2024-2030
- Biotechnology
- Genomics & Genetic Engineering
- Metagenomics Market Outlook
- Genomics & Genetic Engineering
Global Market
Related Markets
Ask Prism AI about the metagenomics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Australia metagenomics market highlights
- The Australia metagenomics market generated a revenue of USD 35.6 million in 2023 and is expected to reach USD 87.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 13.8% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 35.6 million |
| Market revenue in 2030 | USD 87.9 million |
| Growth rate | 13.8% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 244.2 million by 2030.
The presence of well-established healthcare infrastructure & research facilities, favorable reimbursement policies, and availability of world-class researchers are anticipated to be major factors boosting the market in Australia.
In addition, growing public-private partnerships and collaborations in the field of NGS are expected to fuel the growth of Australia metagenomics market. In December 2020, the Victorian government partnered with Illumina & the University of Melbourne to obtain USD 60 million in funding and establish the Illumina–University of Melbourne Genomics Hub.
In September 2020, Australia-based Communicable Disease Genomics Network and U.S.- based Illumina collaborated to trace COVID-19 using the latter’s next-generation genomic sequencing technology. Furthermore, the high prevalence of chronic & infectious diseases, such as cancer & HIV, is propelling the demand for efficient NGS solutions in the country for diagnostic purposes.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Novogene | View profile | 501-1000 | Beijing, Beijing, China, Asia | en.novogene.com/ |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | www.promega.com/es |
| Oxford Nanopore Technologies PLC | View profile | 1,133 | Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQ | www.nanoporetech.com |
Australia Metagenomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 61.52% in 2023.
Horizon Databook has segmented the Australia metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of well-established healthcare infrastructure & research facilities, favorable reimbursement policies, and availability of world-class researchers are anticipated to be major factors boosting the market in Australia.
In addition, growing public-private partnerships and collaborations in the field of NGS are expected to fuel the growth of Australia metagenomics market. In December 2020, the Victorian government partnered with Illumina & the University of Melbourne to obtain USD 60 million in funding and establish the Illumina–University of Melbourne Genomics Hub.
In September 2020, Australia-based Communicable Disease Genomics Network and U.S.- based Illumina collaborated to trace COVID-19 using the latter’s next-generation genomic sequencing technology. Furthermore, the high prevalence of chronic & infectious diseases, such as cancer & HIV, is propelling the demand for efficient NGS solutions in the country for diagnostic purposes.
- Australia Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Others
- Clinical Diagnostics
- Drug Discovery
- Biotechnology
- Environmental
- Food & nutrition
- Australia Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Whole Genome Sequencing
- Shotgun Sequencing
- Others
- 16S Sequencing
- Australia Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
- Sequencing & Data Analytics Services
- Kits & Reagents
- Software
- Australia Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
- Pre-sequencing
- Sequencing
- Data Analysis
Reasons to subscribe to Metagenomics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Metagenomics Market Outlook databook
- Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Metagenomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Australia Metagenomics Market, 2018-2030 (US$M)
Australia metagenomics market statistics, by application, 2018-2030 (US$M)
